Farms.com Home   News

“More positive than anticipated” is how Saskatchewan’s Premier terms meetings with Chinese government officials

Premier Scott Moe is crossing more time zones on Monday only two days after finishing a trade mission to China and Japan last week.

Moe spoke to reporters at the Saskatoon airport prior to departing on a flight to the nation’s capital for additional meetings with Prime Minister Mark Carney and senior cabinet ministers.

Moe and the Prime Minister’s parliamentary secretary Kody Blois met with officials within the Chinese Commerce Ministry—the body that is responsible for implementing import tariffs. It has placed very hefty preliminary tariffs on Canadian canola seed—as well as canola oil, canola meal, peas and pork. Those tariffs were seen as a response to Canadian tariffs on Chinese electric vehicles. That tariff was implemented at the request of the United States.

It’s hoped the trade mission will begin a gradual process to improve relations between Canada and China.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.